CLINICUVETTE Canadian Trademark Information

On Tuesday, April 22, 2003, a canadian trademark registration was filed for CLINICUVETTE by amaxa GmbH *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1175544. The current status of this trademark filing is Interruption of proceeding. The CLINICUVETTE trademark is filed in the description of Chemicals and biological products used in industry and science, namely, soluble substances and solutions for transfer of biological molecules into cells; biological reagents for laboratories and for use in transfection of bioactive molecules into cells; filter material for use within devices for transfer of biological molecules into cells; pharmaceutical and veterinary preparations for the treatment of gene-based diseases, namely, cancer, cardiovascular disorders and malfunctions of the central nerve system, and for use in the field of diagnostics dependent on the delivery of said pharmaceuticals to a target site, and for use in the field of gene therapy; dietetic substances adapted for medical use; microorganisms and biological material for medical and veterinary use, namely cells to be transfected and cells already transfected with biologically active molecules; scientific apparatus and instruments, namely, devices and containers serving for transfection of bioactive molecules into cells as well as devices making possible the detection, selection and/or sorting of cells in which the molecules are transfected; apparatus and instrument devices, namely, electroporators, used for conducting, switching, converting, storing, controlling, guiding and delivering of electricity for electroporaton, electrofusion and electrostimulation of cells. , Chemicals and biological products used in industry and science, namely, soluble substances and solutions for transfer of biological molecules into cells; biological reagents for laboratories and for use in transfection of bioactive molecules into cells; filter material for use within devices for transfer of biological molecules into cells; pharmaceutical and veterinary preparations for the treatment of gene-based diseases, namely, cancer, cardiovascular disorders and malfunctions of the central nerve system, and for use in the field of diagnostics dependent on the delivery of said pharmaceuticals to a target site, and for use in the field of gene therapy; dietetic substances adapted for medical use; microorganisms and biological material for medical and veterinary use, namely cells to .